Adamas Pharmaceuticals Inc short interest in 2018
In 2018, Adamas Pharmaceuticals Inc's disclosed short interest ran from 32.55% of shares outstanding on 12 Jan 2018 to 23.52% on 31 Dec 2018, a change of -9.03 percentage points. The year's high was 33.70% on 29 Mar 2018 and its low 23.52% on 31 Dec 2018, averaging 29.49% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.32 days on 14 Sep 2018. Full history: Adamas Pharmaceuticals Inc.
Cite this page
By year: 2018 · 2019 · 2020 · 2021
2018 in figures
- Start of year
- 32.55% (12 Jan 2018)
- End of year
- 23.52% (31 Dec 2018)
- Change
- -9.03 pp
- High
- 33.70% (29 Mar 2018)
- Low
- 23.52% (31 Dec 2018)
- Average
- 29.49%
- Highest days to cover
- 24.32 (14 Sep 2018)
- SEC filings marked
- 9
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 32.55% | 11.21 | |
| 31 Jan 2018 | 32.12% | 6.60 | results (8-K) |
| 15 Feb 2018 | 30.36% | 8.59 | |
| 28 Feb 2018 | 31.47% | 3.18 | 10-K filed, results (8-K) |
| 15 Mar 2018 | 31.46% | 7.39 | |
| 29 Mar 2018 | 33.70% | 8.14 | |
| 13 Apr 2018 | 32.68% | 13.29 | |
| 30 Apr 2018 | 30.49% | 10.31 | |
| 15 May 2018 | 29.81% | 9.88 | 10-Q filed, results (8-K) |
| 31 May 2018 | 29.61% | 14.19 | |
| 15 Jun 2018 | 31.31% | 14.93 | |
| 29 Jun 2018 | 30.68% | 13.74 | |
| 13 Jul 2018 | 30.78% | 21.25 | |
| 31 Jul 2018 | 30.10% | 18.55 | |
| 15 Aug 2018 | 29.03% | 9.20 | 10-Q filed, results (8-K) |
| 31 Aug 2018 | 28.85% | 18.00 | |
| 14 Sep 2018 | 28.77% | 24.32 | |
| 28 Sep 2018 | 28.04% | 11.21 | |
| 15 Oct 2018 | 27.04% | 12.05 | |
| 31 Oct 2018 | 24.74% | 17.70 | |
| 15 Nov 2018 | 27.15% | 5.73 | 10-Q filed, results (8-K) |
| 30 Nov 2018 | 26.86% | 16.26 | |
| 14 Dec 2018 | 26.71% | 14.07 | |
| 31 Dec 2018 | 23.52% | 7.29 |
See also: Adamas Pharmaceuticals Inc's full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.